evidencegaps
Primary study · included by 1 review

Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study.

Zhou 2023 · Zhou Rui-Qin, Luo Jun, Li Lin-Jun, et al. · BMC surgery · 2023

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Zhou 2023 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.